WHO. WHO Coronavirus (COVID-19) dashboard. 2023.
Limmer A, Engler A, Kattner S, Gregorius J, Pattberg KT, Schulz R, Schwab J, Roth J, Vogl T, Krawczyk A, Witzke O, Zelinskyy G, Dittmer U, Brenner T, Berger MM. Patients with SARS-CoV-2-induced viral sepsis simultaneously show immune activation, impaired immune function and a procoagulatory disease state. Vaccines (Basel). 2023;11(2):435.
Article CAS PubMed Google Scholar
Morris-Love J, Gee GV, O’Hara BA, Assetta B, Atkinson AL, Dugan AS, Haley SA, Atwood WJ. JC polyomavirus uses extracellular vesicles to infect target cells. mBio. 2019;10(2):e00379-19.
Article CAS PubMed PubMed Central Google Scholar
O’Hara BA, Morris-Love J, Gee GV, Haley SA, Atwood WJ. JC Virus infected choroid plexus epithelial cells produce extracellular vesicles that infect glial cells independently of the virus attachment receptor. PLoS Pathog. 2020;16(3):e1008371.
Article CAS PubMed PubMed Central Google Scholar
Handala L, Blanchard E, Raynal PI, Roingeard P, Morel V, Descamps V, Castelain S, Francois C, Duverlie G, Brochot E, Helle F. BK polyomavirus hijacks extracellular vesicles for En Bloc transmission. J Virol. 2020;94(6):e01834-19.
Article CAS PubMed PubMed Central Google Scholar
Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol. 2010;47(4):306–12.
Article PubMed PubMed Central Google Scholar
Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9(4):425–37.
Article CAS PubMed PubMed Central Google Scholar
Morris-Love J, Atwood WJ. Complexities of JC polyomavirus receptor-dependent and -independent mechanisms of infection. Viruses. 2022;14(6):1130.
Article CAS PubMed PubMed Central Google Scholar
Assetta B, Atwood WJ. The biology of JC polyomavirus. Biol Chem. 2017;398(8):839–55.
Article CAS PubMed Google Scholar
Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471–506.
Article CAS PubMed PubMed Central Google Scholar
Suzuki T, Orba Y, Okada Y, Sunden Y, Kimura T, Tanaka S, Nagashima K, Hall WW, Sawa H. The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog. 2010;6(3):e1000801.
Article PubMed PubMed Central Google Scholar
Khalili K, White MK, Sawa H, Nagashima K, Safak M. The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J Cell Physiol. 2005;204(1):1–7.
Article CAS PubMed Google Scholar
Suzuki T, Okada Y, Semba S, Orba Y, Yamanouchi S, Endo S, Tanaka S, Fujita T, Kuroda S, Nagashima K, Sawa H. Identification of FEZ1 as a protein that interacts with JC virus agnoprotein and microtubules: role of agnoprotein-induced dissociation of FEZ1 from microtubules in viral propagation. J Biol Chem. 2005;280(26):24948–56.
Article CAS PubMed Google Scholar
Costa C, Cavallo R. Polyomavirus-associated nephropathy. World J Transplant. 2012;2(6):84–94.
Article PubMed PubMed Central Google Scholar
Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199(6):837–46.
Article CAS PubMed Google Scholar
May D, Bellizzi A, Kassa W, Cipriaso JM, Caocci M, Wollebo HS. IFNα and β mediated JCPyV suppression through C/EBPβ-LIP isoform. Viruses. 2021;13(10):1937.
Article CAS PubMed PubMed Central Google Scholar
Kartau M, Auvinen E, Verkkoniemi-Ahola A, Mannonen L, Helanterä I, Anttila VJ. JC polyomavirus DNA detection in clinical practice. J Clin Virol. 2022;146:105051.
Article CAS PubMed Google Scholar
Cook L, Polyomaviruses. Microbiol Spectr. 2016;4(4). https://journals.asm.org/doi/10.1128/microbiolspec.dmih2-0010-2015
Ray U, Cinque P, Gerevini S, Longo V, Lazzarin A, Schippling S, Martin R, Buck CB, Pastrana DV. JC Polyomavirus mutants escape antibody-mediated neutralization. Sci Transl Med. 2015;7(306):306ra151.
Article PubMed PubMed Central Google Scholar
Antonsson A, Green AC, Mallitt KA, O’Rourke PK, Pawlita M, Waterboer T, Neale RE. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of australians. J Gen Virol. 2010;91(Pt 7):1849–53.
Article CAS PubMed Google Scholar
Kartau M, Sipilä JO, Auvinen E, Palomäki M, Verkkoniemi-Ahola A. Progressive multifocal leukoencephalopathy: current insights. Degener Neurol Neuromuscul Dis. 2019;9:109–21.
CAS PubMed PubMed Central Google Scholar
Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, Ryschkewitsch C, Major EO, Ohayon J, Schindler MK, Beck E, Reoma LB, Jacobson S, Reich DS, Nath A. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med. 2019;380(17):1597–605.
Article CAS PubMed Google Scholar
Atkinson AL, Atwood WJ. Fifty years of JC polyomavirus: a brief overview and remaining questions. Viruses. 2020;12(9):969.
Article CAS PubMed PubMed Central Google Scholar
Corbridge SM, Rice RC, Bean LA, Wüthrich C, Dang X, Nicholson DA, Koralnik IJ. JC virus infection of meningeal and choroid plexus cells in patients with progressive multifocal leukoencephalopathy. J Neurovirol. 2019;25(4):520–4.
Article CAS PubMed PubMed Central Google Scholar
Dang X, Koralnik IJ. A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol. 2006;87(Pt 9):2533–7.
Article CAS PubMed Google Scholar
Koralnik IJ, Wüthrich C, Dang X, Rottnek M, Gurtman A, Simpson D, Morgello S. JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol. 2005;57(4):576–80.
Wüthrich C, Dang X, Westmoreland S, McKay J, Maheshwari A, Anderson MP, Ropper AH, Viscidi RP, Koralnik IJ. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol. 2009;65(6):742–8.
Article PubMed PubMed Central Google Scholar
Delbue S, Ferraresso M, Ghio L, Carloni C, Carluccio S, Belingheri M, Edefonti A, Ferrante P. A review on JC virus infection in kidney transplant recipients. Clin Dev Immunol. 2013;2013:926391.
Article PubMed PubMed Central Google Scholar
Wiseman AC. Polyomavirus nephropathy: a current perspective and clinical considerations. Am J Kidney Dis. 2009;54(1):131–42.
Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis. 2003;3(10):611–23.
Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis. 2005;41(3):354–60.
Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med. 1986;315(4):230–4.
Article CAS PubMed Google Scholar
Drachenberg CB, Hirsch HH, Papadimitriou JC, Gosert R, Wali RK, Munivenkatappa R, Nogueira J, Cangro CB, Haririan A, Mendley S, Ramos E. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84(3):323–30.
Diotti RA, Nakanishi A, Clementi N, Mancini N, Criscuolo E, Solforosi L, Clementi M. JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? Clin Dev Immunol. 2013;2013:967581.
Article PubMed PubMed Central Google Scholar
Chiarinotti D, Ruva CE, David P, Capurro F, Brustia M, Omodeo Zorini E, Benigni E, Turello E, De Leo M, Verzetti G. Polyomavirus infection in an immunocompetent patient and literature overview. G Ital Nefrol. 2002;19(1):74–8.
Di Maida F, Viola L, Lambertini L, Mari A, Mencarini J, Borchi B, Carini M, Zammarchi L, Minervini A. A rare urinary JC virus reactivation after long-term therapy with rituximab. Int J Infect Dis. 2021;103:447–9.
Janphram C, Worawichawong S, Disthabanchong S, Sumethkul V, Rotjanapan P. Absence of JC Polyomavirus (JCPyV) viremia in early post-transplant JCPyV nephropathy: a case report. Transpl Infect Dis. 2017;19(6):e12761. https://onlinelibrary.wiley.com/doi/10.1111/tid.12761.
Sharma N, Abdulkhalek S.
留言 (0)